Dazhi Xu

3.5k total citations
62 papers, 2.6k citations indexed

About

Dazhi Xu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Dazhi Xu has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 17 papers in Molecular Biology. Recurrent topics in Dazhi Xu's work include Gastric Cancer Management and Outcomes (34 papers), Metastasis and carcinoma case studies (16 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). Dazhi Xu is often cited by papers focused on Gastric Cancer Management and Outcomes (34 papers), Metastasis and carcinoma case studies (16 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). Dazhi Xu collaborates with scholars based in China, United States and Taiwan. Dazhi Xu's co-authors include Youqing Zhan, Hui‐Kuan Lin, Xiaowei Sun, Jianjun Liu, Zhaohui Gong, Pengfei Kong, Xuechao Liu, Chengwei Zhou, Guoxiang Jin and Chien‐Feng Li and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Dazhi Xu

59 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dazhi Xu China 25 1.4k 961 819 651 498 62 2.6k
Toshiya Ochiai Japan 26 868 0.6× 788 0.8× 747 0.9× 702 1.1× 733 1.5× 154 2.3k
Rocco Cappellesso Italy 26 720 0.5× 701 0.7× 585 0.7× 604 0.9× 542 1.1× 90 2.0k
Isamu Hoshino Japan 26 1.4k 1.0× 948 1.0× 469 0.6× 603 0.9× 613 1.2× 112 2.5k
Kosei Maemura Japan 36 1.1k 0.8× 977 1.0× 1.6k 2.0× 832 1.3× 933 1.9× 158 3.4k
Takeshi Iwaya Japan 24 1.1k 0.8× 805 0.8× 364 0.4× 569 0.9× 624 1.3× 82 2.1k
Hisashi Ikoma Japan 32 1.1k 0.8× 1.1k 1.2× 1.1k 1.4× 1.2k 1.8× 1.1k 2.2× 238 3.2k
Masatsugu Moriyama Japan 32 1.7k 1.2× 806 0.8× 490 0.6× 512 0.8× 822 1.7× 104 3.1k
Giuseppe Perrone Italy 27 866 0.6× 563 0.6× 1.2k 1.4× 536 0.8× 531 1.1× 122 2.6k
Fan Lin United States 24 1.6k 1.2× 414 0.4× 680 0.8× 411 0.6× 405 0.8× 69 2.7k
Dan Huang China 30 2.3k 1.7× 2.1k 2.2× 1.2k 1.4× 580 0.9× 538 1.1× 131 3.8k

Countries citing papers authored by Dazhi Xu

Since Specialization
Citations

This map shows the geographic impact of Dazhi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dazhi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dazhi Xu more than expected).

Fields of papers citing papers by Dazhi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dazhi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dazhi Xu. The network helps show where Dazhi Xu may publish in the future.

Co-authorship network of co-authors of Dazhi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dazhi Xu. A scholar is included among the top collaborators of Dazhi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dazhi Xu. Dazhi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Caixia, Yulin Zhang, Shujuan Du, et al.. (2025). Co-infection of Helicobacter pylori with Epstein-Barr virus in gastric organoids enhances cell proliferation and morphogenesis. Journal of Virology. 99(9). e0092825–e0092825. 1 indexed citations
4.
Zhang, Jingrong, et al.. (2023). miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway. Biochemical and Biophysical Research Communications. 648. 50–58. 9 indexed citations
5.
Sun, Bo, Haojie Chen, Cong Tan, et al.. (2023). The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma. The Journal of Pathology Clinical Research. 9(5). 409–422. 2 indexed citations
6.
Duan, Yantao & Dazhi Xu. (2023). Microsatellite instability and immunotherapy in gastric cancer: a narrative review. 6. 14–14. 6 indexed citations
7.
Sun, Bo, et al.. (2022). Tumor Location Causes Different Recurrence Patterns in Remnant Gastric Cancer. Journal of the Korean Gastric Cancer Association. 22(4). 369–369. 1 indexed citations
8.
Wu, Juan, Xi Xu, Long Wen, et al.. (2020). Investigation of COVID-19-related symptoms based on factor analysis. Annals of Palliative Medicine. 9(4). 1851–1858. 22 indexed citations
9.
Xu, Dazhi, Quan‐Lin Li, & Ping‐Hong Zhou. (2019). [The safety and feasibility of endoscopic treatment for upper gastrointestinal tract foreign bodies in elderly patients over 80 years old].. PubMed. 22(11). 1078–1081. 1 indexed citations
10.
Li, Shun, Xiaowei Sun, Wěi Li, et al.. (2017). A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4). Oncotarget. 9(4). 4814–4822. 15 indexed citations
12.
Kong, Pengfei, Ruiyan Wu, Chenlu Yang, et al.. (2016). Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer. Scientific Reports. 6(1). 26313–26313. 14 indexed citations
13.
Liu, Jianjun, Qirong Geng, Zhimin Liu, et al.. (2016). Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry. Oncotarget. 7(24). 35853–35864. 38 indexed citations
14.
Sun, Xiaowei, Xuechao Liu, Jianjun Liu, et al.. (2016). Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer. Chinese Journal of Cancer. 35(1). 57–57. 53 indexed citations
15.
Xu, Pengfei, Haibo Qiu, Dazhi Xu, et al.. (2016). Preoperative Nutritional Deficiency Is a Useful Predictor of Postoperative Outcome in Patients Undergoing Curative Resection for Gastric Cancer. Translational Oncology. 9(6). 482–488. 10 indexed citations
16.
Kong, Pengfei, Ruiyan Wu, Xuechao Liu, et al.. (2016). The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis. Journal of Cancer. 7(15). 2247–2257. 28 indexed citations
17.
Sun, Xiao, Pengfei Xu, Haibo Qiu, et al.. (2016). Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer. OncoTargets and Therapy. 9. 949–949. 9 indexed citations
18.
Xu, Dazhi, Chien‐Feng Li, Xian Zhang, et al.. (2015). Skp2–MacroH2A1–CDK8 axis orchestrates G2/M transition and tumorigenesis. Nature Communications. 6(1). 6641–6641. 91 indexed citations
19.
He, Wenzhuo, Chang Jiang, Chenxi Yin, et al.. (2015). A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C. OncoTargets and Therapy. 8. 3135–3135. 30 indexed citations
20.
Wu, Zhengrong, Lirong Wu, Desheng Weng, et al.. (2009). Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. Journal of Experimental & Clinical Cancer Research. 28(1). 8–8. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026